Needless surgery due to flawed cancer test
The controversial finding has been made by the US Preventative Services Task Force, which said the use of the prostate-specific antigen blood test is effectively misdiagnosing patients.
A major study by the independent expert group said the concern is caused by the inability of the test to differentiate between possible prostate cancer which may never pose a risk and its more aggressive, potentially life-threatening form.
